About Nephrology
There are 300 companies in the Nephrology sector across the world, with 209 funded companies having collectively raised $7.75B in venture capital money and private equity. Overall 103 of these are Series A+ funded.
Nephrology sector has seen 26 acquisitions and 27 IPOs. This represents almost 17.7% of all such companies - which is higher than the 4.9% exit rate of tech companies in general.
This sector includes companies developing medical devices, diagnostics tests, and pharmaceuticals for the diagnosis and treatment of kidney diseases.
Nephrology sector is also known as Renal Disease, Chronic Kidney Disease or Kidney Disease.
Companies included in Nephrology sector
Medical devices, diagnostics tests, and pharmaceuticals for the diagnosis and treatment of kidney diseasesCompanies excluded in Nephrology sector
Healthcare Service Providers, Digital Health Solutions (software, apps, online platforms)Market Map of Nephrology
The market map of Nephrology gives a visual overview of the sector, showing key business models, their interactions in the value chain, and industry evolution. Trending business models in Nephrology sector are Renal Replacement Devices and Acute Kidney Disease Drugs.
Reports related to Nephrology
Here are some reports related to Nephrology sector:
Free
Nephrology - Sector Report
Edition: May, 2025 (62 Pages)
Premium
Nephrology Investor Landscape
Edition: July, 2025 (12 Pages)
Premium
Nephrology Exit Landscape
Edition: November, 2025 (15 Pages)
View all reports related to Nephrology. Sign up today!Top Companies in Nephrology
There are more than 300 companies in Nephrology. Sequana Medical is the top Nephrology company globally, ranked using Tracxn Score (what's this?).
Here are 5 of the top Nephrology companies globally:
Company | Description | Location | Founded | Current Stage | Private Funding Raised |
|---|---|---|---|---|---|
Developer of implantable battery-powered pump for removal of ascites | Zurich (Switzerland) | 2006 | Public | $35.5M | |
Developer of therapeutics for the gastrointestinal tract, cardio-renal, GI, and metabolic diseases | Fremont (United States) | 2007 | Public | $61.1M | |
Provider of small molecule based drug for inflammatory kidney disease | Stockholm (Sweden) | 2004 | Public | $44.8M | |
Developer of therapeutics for diseases with impaired kidney function | Lyon (France) | 2014 | Series C | $120M | |
Developer of therapeutics for gout, chronic kidney diseases, and oncology | Irvine (United States) | 2017 | Acquired | $293M |
Companies founded year-on-year in the Nephrology sector
28 Nephrology startups were founded in 2019 - this is the most number of startups founded in any year in the last 10 years.
- Total Number of Companies
Year | No. of companies |
|---|---|
2026 | - |
2025 | 2 |
2024 | 4 |
2023 | 6 |
2022 | 8 |
2021 | 12 |
2020 | 16 |
2019 | 28 |
2018 | 20 |
2017 | 22 |
Companies founded across countries in the Nephrology sector
United States has 147 Nephrology startups, the most by any country, followed by India which has 25 startups and China which has 13.
- Total Number of Companies
Country | No. of companies |
|---|---|
United States | 147 |
India | 25 |
China | 13 |
United Kingdom | 11 |
Switzerland | 11 |
Israel | 10 |
Sweden | 10 |
Germany | 10 |
Canada | 9 |
Netherlands | 8 |
Stage-wise distribution of the Nephrology sector
Out of the total 300 Nephrology companies, 209 have secured funding. Among them, 103 have reached Series A or higher, and 76 to Series B or beyond.
Founded - 300
Funded - 209
Series A+ - 103
Series B+ - 76
Series C+ - 63
Company Stage | No. of companies |
|---|---|
Founded | 300 |
Funded | 209 |
Series A+ | 103 |
Series B+ | 76 |
Series C+ | 63 |
Want to know more about Nephrology ? Signup and explore Tracxn for free
- 295+ Total Companies
- $7.75B+ Total Funding
- 205+ Funded Companies
- 25+ IPOs
- 25+ Acquisitions
- 5+ Reports
Funding Trends in the Nephrology sector
Total funding year-on-year in the Nephrology sector
The Nephrology sector saw a total funding of more than $4.58B in the last 10 years. The most amount of funding was in 2019 at more than $796M. There has been a total funding of $250K in 2026 till date.
- Total Funding
Year | Total Funding |
|---|---|
2026 | $250K |
2025 | $308M |
2024 | $728M |
2023 | $584M |
2022 | $326M |
2021 | $636M |
2020 | $400M |
2019 | $796M |
2018 | $473M |
2017 | $330M |
Total funding across countries in the Nephrology sector
In the last 10 years, Nephrology startups in United States have recieved the highest funding among all countries - $2.87B. Canada follows with $417M and United Kingdom with $411M.
- Total Funding
Country | Total Funding |
|---|---|
United States | $2.87B |
Canada | $417M |
United Kingdom | $411M |
China | $215M |
Switzerland | $158M |
France | $119M |
Japan | $67.1M |
Sweden | $43.6M |
Israel | $19.4M |
India | $6.88M |
Total funding amount raised by stage in the Nephrology sector
Over the last 10 years, the Nephrology sector have seen $154M into Seed Stage funding rounds, $1.74B into Early Stage funding rounds and $1.57B go into Late Stage funding rounds.
Funding Stage | Total Funding |
|---|---|
Early Stage | $1.74B |
Late Stage | $1.57B |
Post IPO | $612M |
Debt | $336M |
Seed Stage | $154M |
Grant | $95.3M |
Recent Funding Rounds in Nephrology
In the year 2026, till March 2026, Nephrology companies have raised $250K in equity funding across 1 round.
In the same period last year (i.e. till March 2025), Nephrology companies had raised $6.55M across 3 rounds.
So, 2026 has seen a 96.18% drop in funding in Nephrology companies as compared to 2025.
Here are some recent, important funding rounds in Nephrology:
Company | Round Raised | Amount Raised | Funding Date | Investors |
|---|---|---|---|---|
Series B | 3911 | Mar 24, 2026 | ||
Seed | 1555 | Oct 24, 2025 | and 2 more | |
Series B | 3855 | Oct 22, 2025 | ||
Seed | 9868 | Oct 01, 2025 | and 1 more | |
Seed | 5748 | Sep 09, 2025 | and 2 more |
Top Investors in Nephrology
HHS is the top investor in Nephrology companies based on number of companies invested.
Here are some top investors in Nephrology:
Investor | Location | Top Portfolio Companies |
|---|---|---|
Washington, DC (United States) | ||
New York City (United States) | ||
Brussels (Belgium) | ||
Paris (France) |
M&A activity in Nephrology
In the year 2026, till January 2026, 1 acquisition happened in Nephrology sector. Last year, in 2025, a total of 3 acquisitions happened in Nephrology sector.
Here are some recent, important acquisitions in Nephrology:
Company | Acquisition Type | Acquisition Date | Acquirers |
|---|---|---|---|
Business Acquisition | Jan 21, 2026 | ||
Business Acquisition | Dec 14, 2025 | ||
Business Acquisition | Nov 26, 2025 | ||
Business Acquisition | Oct 24, 2025 | ||
Business Acquisition | Jan 05, 2024 |
Acquisition trends in Nephrology
Here are the acquisition trends in Nephrology:
- Total Number of Acquisitions
Year | No. of companies |
|---|---|
2026 | 1 |
2025 | 3 |
2024 | 1 |
2023 | 3 |
2022 | - |
2021 | 1 |
2020 | - |
2019 | 2 |
2018 | 2 |
2017 | 2 |
IPOs in Nephrology
In the year 2023, till July 2023, 3 IPOs happened in Nephrology sector.
Here are some recent, important IPOs in Nephrology:
Company | IPO Date | Exchange Symbol |
|---|---|---|
Jul 21, 2023 | Frankfurt Stock Exchange (FRA) | |
Feb 01, 2023 | National Association of Securities Dealers Automated Quotations (NASDAQ) | |
Jan 20, 2023 | National Association of Securities Dealers Automated Quotations (NASDAQ) | |
Dec 12, 2022 | National Association of Securities Dealers Automated Quotations (NASDAQ) | |
Jul 12, 2022 | National Association of Securities Dealers Automated Quotations (NASDAQ) |
_1557401318895.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Colleges which produce the most Nephrology companies
Companies founded by alumni from top colleges in the Nephrology sector
Most number of Nephrology startups have been founded by alumni from University of Chicago, University of Pennsylvania and Stanford University.
College | No. of companies |
|---|---|
University of Chicago | 6 |
University of Pennsylvania | 5 |
Stanford University | 4 |
University of Oxford | 4 |
Duke University | 3 |
Harvard Business School | 3 |
University of California (Berkeley) | 3 |
University of California (Los Angeles) | 3 |
Yale University | 3 |
Booth School of Business | 2 |
Total funding in companies founded by alumni from top colleges in the the Nephrology sector
In the last 10 years, University of Chicago graduates' Nephrology companies have raised the most funding among top colleges. University of Pennsylvania alumni are second, and University of Michigan - Stephen M. Ross School of Business alumni are third.
College | Total Funding |
|---|---|
University of Chicago | $557M |
University of Pennsylvania | $219M |
University of Michigan - Stephen M. Ross School of Business | $173M |
University of California (Berkeley) | $147M |
Harvard Business School | $105M |
Duke University | $78.2M |
Yale University | $62.8M |
Massachusetts Institute of Technology | $43.7M |
Kellogg School of Management | $38.2M |
Harvard University | $25.4M |
Top News in Nephrology
•
Cadrenal Therapeutics Provides Update on CAD-1005 Program Following FDA MeetingGlobeNewswire•Mar 31, 2026•Cadrenal Therapeutics
•
•
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) NDA ResubmissionGlobeNewswire•Jan 29, 2026•Unicycive
•
Lisata Therapeutics Mutually Terminates License Agreement with Qilu PharmaceuticalGlobeNewswire•Jan 27, 2026•Lisata
•
•
•
•
Simergent Announces FDA Clearance of the Archimedes™ Home Dialysis SystemPR Newswire•Oct 14, 2025•Simergent
•
PatenSee Receives FDA Breakthrough Device Designation for Vascular Access ManagementPR Newswire•Sep 16, 2025•FDA, PatenSee
•
Shanton Receives Fast Track Designation from US FDA for Refractory Gout ProgramPR Newswire•Jul 25, 2025•SHANTON
